Clinical trial / 1983
Ingestion of choline chloride, choline stearate, or lecithin increased urinary excretion of methylamines in healthy human subjects.
Healthy human subjects were administered 27 millimoles of choline chloride, choline stearate, or lecithin. These treatments markedly increased urinary excretion of TMA, DMA, and MMA, with choline chloride showing the greatest effect. Rats treated with 2 mmol/kg b.wt. of choline chloride or lecithin showed significantly increased urinary TMA excretion without alterations in DMA or MMA excretion. Commercially available lecithins and choline stearate were found to be contaminated with methylamines, and prior removal of methylamines from lecithin minimized its effect on urinary methylamine excretion in both rats and humans.
- Study type
- Interventional trial in humans and animals
- Who was studied
- Healthy human subjects (sample size not specified) and rats
- What was measured
- Urinary excretion of trimethylamine (TMA), dimethylamine (DMA), and monomethylamine (MMA)
THE PAPER
Formation of methylamines from ingested choline and lecithin.
Zeisel SH, Wishnok JS, Blusztajn JK. J Pharmacol Exp Ther, 1983.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.